Monitor blood pressure regularly, ideally at home and in the clinic. Target blood pressure reduction should be gradual to avoid sudden drops. Initial dosage adjustments are typically small, perhaps 30-60mg daily. If blood pressure remains inadequately controlled after two to four weeks at the maximum tolerated dose of a given formulation, consider switching to a different formulation or adding another antihypertensive medication. For example, consider adding a diuretic or ACE inhibitor.
Significant blood pressure drops (e. g., systolic below 90 mmHg or a drop of more than 20 mmHg from baseline) require immediate dose reduction. Symptoms like dizziness or lightheadedness also warrant dosage adjustment. Consult a physician for personalized guidance, especially in the presence of co-morbidities like heart failure or renal impairment.
Sustained-release formulations may require less frequent dosage adjustments compared to immediate-release versions. However, consistent monitoring remains critical for optimal efficacy and safety. Careful patient education on potential side effects is essential for proactive management and adherence to the treatment plan. Regularly review the treatment plan with the patient’s physician to ensure it remains appropriate and effective.
Remember, individual responses to Diltiazem vary. This information should not replace professional medical advice. Always follow your physician’s recommendations.
